Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Brasilia，Brazil——Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") obtained the regulatory approval by Brazil ANVISA for its independently developed PathBuilder™ Steerable introducer ，PathBuilder™ Transseptal Guiding Introducer and Needle ("PathBuilder™").
Arrhythmia is a common disease of cardiovascular diseases, and RF ablation is an important treatment for arrhythmia. The PathBuilder™ is specially indicated for the RF ablation of cardiac arrhythmias. It is used to enter the femoral vein and establish a vascular access, and guide the diagnostic catheter or ablation catheter to enter each cardiac chamber，assist catheter to target position and provide support.
Previously, the proprietary equipment and catheters independently developed by MicroPort EP have already been approved by Brazil ANVISA .The PathBuilder™ Set Products approval will provide more comprehensive solutions in electrophysiology, which lays a solid groundwork for the company’s further exploration in the South America market.
In the future, MicroPort EP will continue to build a differentiated product portfolio and expand its global reach, offering comprehensive solutions for diagnosis and therapy of EP interventions worldwide.
